CDEK
← All organizations
OptiNose AS

OptiNose AS

For profitWebsite ↗

Also known as: OptiNose US | Optinose US Inc. | OPTINOSE US INC

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Jan 1, 2011

First marketed drug

Sep 18, 2017

Last known activity

Apr 18, 2025

Acquired by Paratek Pharmaceuticals Inc → Novo Nordisk on Mar 20, 2025

Timeline

2000s

  1. Jan 1, 2000

    OptiNose AS— Founded

2010s

  1. Sep 18, 2017

    fluticasone— NDA Secondary Org

2020s

  1. Sep 18, 2023

    Novo Nordisk— Now

  2. Mar 20, 2025

    Paratek Pharmaceuticals Inc— Acquired By

Drugs by trial phase (4 distinct, 15 trials)

Phase 3 (2 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

Recent trials (25)

Details

Founded
Oslo, NO Jan 1, 2000
Last known activity
Apr 18, 2025